There was a significant interaction for major or NMCR bleeding in patients with PAD treated with rivaroxaban compared with warfarin ( HR : @ , @ % CI : @-@ @ ) compared with those without PAD ( HR : @ , @ % CI : @-@ @ ; interaction P = @ ) .